Inquiry Basket
Loading ......
Creative Diagnostics provides Anti-PEG Antibodies as high-performance immunological reagents which detect PEGylated compounds in biological samples with high precision. The antibodies from Creative Diagnostics offer specific binding and high sensitivity and excellent reproducibility to help scientists measure PEG modifications in their research and biopharmaceutical work.
The antibodies undergo strict quality control procedures and analytical validation to produce reliable results for PEG Antibodies from Creative Diagnostics offer researchers dependable tools for PEG-related studies through their optimized binding performanceylated therapeutic drug testing and pharmacokinetic studies and immunogenicity assessments. The Anti-PEG and broad assay compatibility which enables reliable detection and confident data interpretation in preclinical and clinical research.
The Anti-PEG Antibodies from Creative Diagnostics serve multiple research purposes for studying PEGylated drugs and nanoparticles through various applications:
Creative Diagnostics provides Anti-PEG Antibodies as high-quality immunological reagents which serve to detect and measure PEGylated compounds in biological samples. The antibodies show precise binding to PEG structures through their high affinity and specific recognition which results in pure products with stable performance and reliable analytical results. The antibodies demonstrate strong binding properties which enable precise measurement of PEGylated drugs and nanoparticles and bioconjugates in multiple scientific research fields.
Anti-PEG Antibodies from Creative Diagnostics serve multiple purposes including ELISA assay development and immunogenicity assessment and pharmacokinetic evaluation and quality control studies. The antibodies from Creative Diagnostics offer dependable results through their validated performance and consistent batch quality which enables PEG-related drug development and immune response monitoring and biopharmaceutical characterization with confidence.
High Affinity & Specificity
Precisely recognizes PEG and its derivative structures, with excellent binding affinity for PEG chain length and terminal groups, and no nonspecific reactivity.
Excellent Sensitivity
Detects PEG-modified molecules down to the ng/mL level, making it suitable for microsample analysis.
Broad Reactivity
Compatible with the detection of various types of PEG-modified drugs, proteins, liposomes, and nanoparticles.
Optimized for ELISA and other immunoassays
Stable and reliable performance in applications such as ELISA, Western blot, and flow cytometry.
Low Background & High Signal-to-Noise Ratio
Ensures clear and reproducible test results, minimizing interference factors.
Validated Analytical Performance
Rigorous methodological validation ensures data accuracy and reproducibility.
Batch-to-Batch Consistency
Batch-to-Batch antibody consistency ensures consistent performance across all batches, ensuring experimental consistency.
Compatible with Complex Matrices
Maintains excellent detection performance in biological samples such as serum, plasma, and cell lysates.
Robust Stability
Maintains activity despite multiple freeze-thaw cycles, long-term storage, and diverse experimental conditions.
Anti-PEG Antibodies from Creative Diagnostics provide researchers with high-quality immunologically active reagents that have been well-characterized for detecting and measuring PEGylated compounds in biological samples. The antibodies contain specific structures that detect PEG and its conjugates in biological samples for quantitative PEG-modified drug and nanocarrier detection.
The production process of each batch follows strict quality control procedures to maintain consistent binding properties and structural integrity and extended operational stability which enables reliable results in multiple laboratory and animal-based studies. The production process includes optimized antigen design and antibody validation and assay compatibility testing to achieve better analytical precision and reproducibility. The Anti-PEG Antibodies from Creative Diagnostics offer dependable solutions for immunogenicity tests and PEG detection assay creation and pharmacokinetic studies and quality control of PEGylated therapeutic drugs.
Anti-PEG Antibodies
| Cat# | Product Name | Description | Application | |
| DMABT-Z60095 | Rabbit Anti-PEG Mab, IgG, Biotin | Detects both linear and branched PEG. | IHC-P, ELISA, WB | Inquiry |
| DMABT-Z60369 | Rabbit Anti-PEG Mab, IgM | Binds to the PEG backbone. | WB, ELISA | Inquiry |
| DMABT-Z60567 | Rat Anti-PEG Mab, IgM | Displays high affinity to both short and long PEG molecules. | WB, ELISA | Inquiry |
| CABT-L3139 | Biotinylated DMABT-Z60567 | Inquiry | ||
| CABT-L3126 | Mouse Anti-PEG Mab, IgG1 | Detects repeating subunits present in PEG. | ELSIA, WB, IHC, FC | Inquiry |
| CABT-L3127 | Mouse Anti-PEG Mab, IgG1 | Binds to the PEG backbone. Detects PEGylated compounds. | ELSIA, WB, IHC | Inquiry |
| CABT-L3133 | Biotinylated CABT-L3127 | Inquiry | ||
| CABT-L3128 | Mouse Anti-PEG Mab, IgG1 | Detects backbone of PEG molecule. Detects PEGylated compounds. | ELISA, WB, FC | Inquiry |
| CABT-L3134 | Biotinylated CABT-L3128 | Inquiry | ||
| CABT-L3129 | Mouse Anti-mPEG Mab, IgG2b | Detects the terminal methoxy group of PEG. Suitable for detection of PEGylated liposomes and nanoparticles. | ELISA, WB, FC | Inquiry |
| CABT-L3136 | Biotinylated CABT-L3129 | Inquiry | ||
| CABT-L3130 | Rat Anti-PEG Mab, IgG2a | Detects PEGylated compounds. Higher affinity, Wider binding range than CABT-L3128. | ELISA | Inquiry |
| CABT-L3135 | Biotinylated CABT-L3130 | Inquiry | ||
| CABT-L3131 | Mouse Anti-PEG Mab, IgM | Binds to the PEG backbone, detects PEGylated compounds. | ELSIA, WB, IHC, FC | Inquiry |
| CABT-L3137 | Biotinylated CABT-L3131 | Inquiry | ||
| CABT-L3132 | Mouse Anti-PEG Mab, IgM | Recognizes PEG backbone. Binds to PEGylated nanoparticles or long-chain PEGylated molecules. | WB, ELISA, IHC, FC | Inquiry |
| CABT-L3138 | Biotinylated CABT-L3132 | Inquiry |
Human Anti-PEG Standards
| CABT-L3140 | Chimeric Human Anti-PEG Mab, IgG1 | Fusion protein of mouse CABT-L3127 VH and VL with human IgG1. | Inquiry |
| CABT-L3141 | Chimeric Human Anti-PEG Mab, IgM | Fusion protein of mouse CABT-L3132 VH and VL with human IgM. | Inquiry |
| CABT-L3142 | Humanized Anti-PEG Mab, IgG1 | Recombinant antibody composed of humanized CABT-L3128 VH and VL with human IgG1 constant regions. | Inquiry |
Combination Packages
| CABT-L3143 | Chimeric Anti-PEG Mab (Set) | This set contains 4 chimeric antibodies composed of the CABT-L3127 variable region genes fused to different human IgG constant domains (IgG1, IgG2, IgG3, and IgG4). | Inquiry |
| CABT-L3144 | Chimeric Anti-PEG Mab (Set) | CABT-L3143; CABT-L3141. | Inquiry |
Time-course analysis of anti-PEG antibody response in rodents shows early detection and reproducible quantification using Anti-PEG Antibodies.
Monitoring Immunogenicity of PEGylated Therapeutics Using Anti-PEG Antibodies
Background:
A biotech company worked on creating a PEGylated protein therapeutic which would increase drug circulation duration and enhance its availability in the body. The preclinical research revealed unexplained drug effectiveness differences because test animals developed antibodies against PEG which led to drug elimination.
Objective:
The research aimed to identify anti-PEG antibodies and measure their levels while studying drug immunogenicity effects on pharmacokinetic properties of the PEGylated protein.
Method:
The research involved two main steps.
The researchers tested the assay with PEGylated standards to confirm its ability to detect both specific and non-specific targets.
Results:
Conclusion:
The Anti-PEG Antibody test enabled scientists to track immune reactions against PEGylated drugs which helped them evaluate safety during preclinical tests and develop better therapeutic compounds. The research proved that Creative Diagnostics' Anti-PEG Antibodies showed exceptional performance in detecting specific antibodies within complex biological samples.
The antibodies recognize PEG chains which exist on your molecules through specific binding mechanisms. The antibodies recognize PEG structures which enables them to detect PEG modifications on proteins and lipid nanoparticles and polymer-based materials.
The antibodies function optimally for ELISA but they also perform well in Western blot and flow cytometry and additional immunoassays for PEGylated compound detection.
The antibodies maintain their sensitivity and produce minimal background signals when detecting PEG in complex biological samples including blood plasma.
The quality control process for each batch includes performance validation to achieve identical binding results which ensures data consistency between different antibody lots.
The antibodies serve as perfect for immunogenicity research because they enable researchers to track anti-PEG antibody development and assess potential immune reactions against PEG-modified drugs.
Loading ......
